Myriad Genetics Collaborates with GSK to Improve Access to HRD Testing in 9 Countries June 12, 2024 New sponsored testing program leverages Myriad’s MyChoice Tests for patients with high-grade serous ovarian cancer SALT LAKE CITY, June 11, 2024 (GLOBE NE... Continue Reading